Pulmonary Hypertension Associated with Connective Tissue Disease.
Fayed H, Coghlan JG.
Semin Respir Crit Care Med. 2019 Apr;40(2):173-183. doi: 10.1055/s-0039-1685214. Epub 2019 May 28.
PMID:31137058
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ, Korkmaz C.
Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17.
PMID:36396789
EULAR recommendations for the treatment of systemic sclerosis: 2023 update.
Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Čolić J, Santiago T, Suliman YA, Matucci-Cerinic M, Gabrielli A, Distler O, Hoffmann-Vold AM, Castellví I, Balbir-Gurman A, Vonk M, Ananyeva L, Rednic S, Tarasova A, Ostojic P, Boyadzhieva V, El Aoufy K, Farrington S, Galetti I, Denton CP, Kowal-Bielecka O, Mueller-Ladner U, Allanore Y.
Ann Rheum Dis. 2025 Jan;84(1):29-40. doi: 10.1136/ard-2024-226430. Epub 2025 Jan 2.
PMID:39874231
Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Kularatne M, Boucly A, Savale L, Solinas S, Cheron C, Roche A, Jevnikar M, Jaïs X, Montani D, Humbert M, Sitbon O.